The full launch of the ADDoPT project has been welcomed by a range of stakeholders in the £20.4m government-industry-academia collaboration, which is working across the pharmaceutical value chain to define a system for the top-down, knowledge-driven Digital Design and Control of drug products and their manufacturing processes.
Alison Clough, Acting Chief Executive of the Association of the British Pharmaceutical Industry, commented,
“We welcome the Government’s commitment to continuing to develop the UK’s life sciences sector. This project will help to put the UK in a position to make innovative medicines available to UK patients more quickly by futureproofing our advanced pharmaceutical manufacturing sector. By reducing the risks associated with the manufacture of medicines we can provide the UK with a competitive advantage in a globally significant sector.”
"This is a great result for UK medicines manufacturing and I look forward to seeing the new technology being applied to biologics so that we can continue to address unmet patient need with the most innovatively designed and effective treatments possible."
Read the full press release here. http://www.psenterprise.com/news/press_releases/160128_addopt/index.html
28th January 2016